Moreover, a recent study revealed that the serum level of sIL-6R, but not IL-6 or TNF-α, is significantly associated with the pathogenesis of the treatment-resistant major depressive disorder, suggesting that IL-6 trans-signaling may be involved in the onset of this disease (Yamasaki et al., 2020). This evidence concerns the gene IL6 and major depressive disorder.